InsidersTradesSigma
Follow the PHARMANUTRA PHARMANUTRA - PHN: THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS AS AT DECEMBER 31, 2025 share price and the full directors' dealings record of the company, a listed issuer based in Italy. Shares are quoted on the IT market, under the supervision of Consob. Operating in the Health Care sector, PHARMANUTRA PHARMANUTRA - PHN: THE BOARD OF DIRECTORS APPROVED THE DRAFT FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS AS AT DECEMBER 31, 2025 has logged 0 insider filings. Market capitalisation: €787.1m. The full history is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
PHARMANUTRA is a company operating in the health and pharmaceutical sector. The board of directors approved the draft financial statements and the consolidated financial statements as of December 31, 2025.